New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

In a 71-week, double-blind study, Nova Nordisk—creators of the popular weight loss drug Wegovy—says their oral semaglutide ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

Trump said his administration reached an agreement with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 weight loss ...

Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.

You can switch from Ozempic® to another medication, but you’ll likely need to start on a low dose of the new medication. Ozempic® is a diabetes drug from the pharmaceutical manufacturer Novo Nordisk.

If you've tried the usual weight loss approaches-eating well, moving your body and tracking what you consume-but you're still ...

The Trump administration has struck a deal to cut prices on popular weight loss drugs like Ozempic, expanding Medicare and Medicaid coverage to make them more affordable.